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Abstract:  
Every year 200,000 women in the United States are diagnosed with breast cancer.  
Of the cases diagnosed, 10% -15% are classified as triple negative breast cancer (TNBC) 
due to the absence of estrogen, progesterone, and HER-2/Neu receptors.  This breast 
cancer sub-type is markedly more aggressive and twice as likely to develop in 
premenopausal women.  TNBC is resistant to endocrine therapies and current targeted 
agents, making clinical need for the development of validated therapeutics for TNBC a 
pressing matter.  To initiate drug development, the internalization of directly 
immunolabeled epidermal growth factor receptors (EGFR) in SK-BR-3 human breast 
adenocarcinoma cells was quantitated using live-cell multiphoton microscopy for 30 
minutes over 5 minute intervals. EGFR targeting is of interest because its internalization 
triggers the signaling pathway that disrupts cell-cell adhesion and induces cell motility. 
The images acquired were processed using ImageJ and analyzed through line profiles. 
After measuring the full width half max at each time point of the 30-minute time series, it 
was determined that significant EGFR internalization did not occur.  
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1. INTRODUCTION 
 
Breast cancer currently accounts for 15% of cancer-related deaths in women and 
is the most common cancer in women worldwide. (1-2). In the United States alone, there 
are 200,000 invasive breast cancer cases and 50,000 in situ breast cancer cases diagnosed 
each year (1,3). Breast cancers can generally be categorized into three sub-types: 
hormone receptor positive tumors, HER-2/Neu amplified tumors, or triple negative 
tumors. The expression of estrogen receptors and progesterone receptors indicates 
hormone receptor positive tumors. HER-2/Neu is a member of the epidermal growth 
factor receptor (EGFR) family of tyrosine kinase receptors (RTK). Its overexpression 
indicates HER-2/Neu amplified tumors. With triple negative tumors, however, all three of 
these types of receptors are absent. Triple negative breast cancer (TNBC) makes up 10%-
15% of breast cancer cases, with women under 40 years old being twice a likely to 
develop this subtype than women over 60 years old (1,4).  There are 6 classifications of 
TNBC that have been identified: basal-like (BL1 and BL2), immunomodulatory (IM), 
mesenchymal (M), mesenchymal stem-like (MSL), and luminal androgen receptor 
(LAR).  These classifications are determined through immunohistochemistry and 
fluorescence assessment using in situ hybridization technique. About 75% of TNBC 
cases diagnosed are basal-like (5).  TNBC is typically diagnosed as having a higher 
histologic grade than other breast cancer types.  This higher grade indicates high 
aggression, poor prognosis, increased recurrence three years after diagnosis, and high 
five-year mortality.  Because TNBC lacks estrogen, progesterone, and HER-2/Neu 
receptors, the treatment options available are limited due to tumors not responding to 
endocrine therapies and current targeted agents (3-4).  
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 In TNBC cells, the 
signaling leading to 
invasiveness and metastasis is 
known. When epidermal 
growth factor (EGF) binds to 
EGFR, the receptor dimerizes 
and trans-phosphorylates the 
Tyr1068 and Tyr1086 regions 
of the receptor. This causes 
GEP100, a guanine nucleotide 
effector protein, to be 
recruited and its pleckstrin 
homology domain to bind with the heavily phosphorylated regions of the EGFR. This 
interaction causes Arf6 to be activated and to be recruited. Arf6 regulates endocytosis and 
recycling of plasma membrane components and, when activated, causes cell metastasis, 
invasion, and proliferation. AMAP1, an effector protein of the activated Arf6, is recruited 
to interact with Arf6. This signaling cascade, shown in Figure 1, induces cells to develop 
a motile phenotype, in which E-cadherin-based cell-to-cell adhesion is lost and the tumor 
cells become invasive and metastatic (5-7). When a ligand binds to RTKs, they 
experience ligand-enhanced internalization after 15 minutes into the endocytic pathway 
and they continue signaling within endosomes (8-10).  
The absence of well-defined molecular targets and the heterogeneity of the 
disease make the clinical need for TNBC specific therapies imperative (11). To begin to 
Figure 1: Illustration of EGFR-GEP100-Arf6-AMAP1 
signaling cascade seen in breast cancer leading to invasion 
and metastasis.  When EGF binds to EGFR, the Tyr1068 and 
Tyr1086 regions of the receptor highly phosphorylate and 
bind the pleckstrin homology domain of GEP100.  Through 
this binding, GEP100 activates and recruits Arf6 and 
downstream signaling employs AMAP1 as its effector.  This 
signaling pathway causes E-cadherin-based cell-cell adhesion 
to be disrupted.    
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develop validated therapeutic targets for TNBC, the cell biology behind EGFRs must be 
clarified. To initiate this task, EGFR was fluorescently labeled in SK-BR-3 human breast 
adenocarcinoma cells to quantify the amount of extra- and intracellular EGFR using live-
cell multiphoton microscopy. 
 
2. MATERIALS AND METHODS 
 
2.1 Cell Culture 
SK-BR-3 cells, obtained from the American Type Culture Collection (ATCC), 
were cultured in DMEM (ATCC) consisting of 10% fetal bovine serum (ATCC) and 5% 
penicillin/streptomycin (Gibco) at 37°C in 5% CO2.  Cells were passaged up to P4 to 
maintain EGFR expression (12).  At least 12 hours prior to image acquisition, the cells 
were cultured onto 25 mm round coverslips (VWR) with 100,000 cells per mL under 
serum-starved conditions in DMEM (ATCC) consisting of 10% charcoal stripped fetal 
bovine serum (Gibco, cat. 12676-029) and 5% penicillin/streptomycin at 37°C in 5% CO2 
(8).   
 
2.2 Direct Immunolabeling 
 
 Prior to image acquisition, the serum-starved cells on the cover slip were directly 
labeled with 10µg/mL Alexa Fluor 488-conjugated mouse anti-human ErbB2 monoclonal 
antibodies (mAb) from Biolegend (clone: AY13, cat. 352907) or 10µg/mL Alexa Fluor 
mouse mAb IgG1 control (clone: MOPC-21, cat. 400132) from Biolegend diluted in 1x 
PBS with and DAPI for 30 minutes on ice in the dark.  After incubation, the cells were 
washed with 1x PBS three times.  Once labeled, the cover slip was placed into an adapter 
and 2mL of Tyrode’s buffer solution was added.  
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2.3 Image Acquisition 
 
Live-cell multiphoton imaging was performed using a Mai Tai femtosecond 
pulsing Ti:Sapphire laser (Spectra Physics) and a 40x water immersion objective with a 
0.8 NA (Nikon).  An overview of the multiphoton microscope set-up used can be seen in 
Figure 2.   
 
Figure 2: Schematic overview of multiphoton microscope with a femtosecond pulsing 
Ti:Sapphire laser and a 40x water immersion 0.8 NA objective.  	
All images were captured with an incident laser power of 20mW.  Initially, the 
DAPI stained nuclei were capture at a wavelength of 720nm at 200 frames per second 
and 50% of maximum gain of photomultiplier tubes to properly align cells. Then, for the 
live-cell study to capture the Alexa Fluor 488-conjugated mouse anti-human EGFR mAb 
being internalized, a time series was established to image every 300 seconds for a total of 
6 measurements (total time of 30 minutes).   The images were acquired at 200 frames per 
second with a laser wavelength of 930nm, using 50% of maximal gain of the 
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photomultiplier tubes, and with a 512µm x 512µm acquisition field of view.  Once the 
time series was completed, the DAPI was imaged a second time with the same 
parameters used initially at 720nm.  			
2.4 Image Analysis 
Following acquisition, the images were loaded into ImageJ for analysis.  The 
images of the 3 time series captured were stacked and merged with their corresponding 
DAPI image. This served to visualize the trafficking of EGFR and qualitatively 
determine if internalization occurred.  Then, lines were manually drawn through the 
centers of 6 imaged cells to develop a line profile of EGFR location at each of the 6 time 
points within the 30 minutes of the live-cell image capture at 930nm.  The line profile 
provided data for gray value of the image verses the length of the line drawn in microns.  
From the graphs generated with this data, the full width half max (FWHM) was measured 
from the peaks present.  The average FWHM from the 6 cells at each time point was then 
calculated and at t-test (p=0.05) was conducted between 5-minute and 30-minute time 
point averages to determine if a statistical difference existed.   
 
3. RESULTS AND DISCUSSION 
 
After the images of the DAPI captured at 720nm and the time series images of 
anti-EGFR captured at 930nm were acquired, they were merged to form a single image 
for each time point within ImageJ. By observation of the cells in these merged images, it 
appeared that the band of EGFR at the surface of the cell was thinner at the 5-minute time 
point than it was at the 30-minute time point (Figure 3).  It was believed this band 
thickening was qualitative evidence of EGFR internalization.      
	 8	
 
 
 	 	 	 	
 
Figure 3: Time series images of a live SK-BR-3 cell over a 30-minute period, showing 5 
intervals.  Cells were labeled with DAPI and anti-EGFR and images were acquired with an 
excitation wavelength of 720nm and 930nm, respectively.  Scale bar represents 10 microns. 	
 To quantitate EGFR internalization, the line profiles of 6 cells imaged at 930nm 
were collected for each time point.  As seen in Figure 4 (A), there were 2 peaks at every 
time point signifying the locations of the cell surface along the center-line drawn where 
the EGFR was located.  If internalization were occurring these peaks would theoretically 
widen as time progressed.  This widening was thought to have been qualitatively seen in 
Figure 3.  The data from the line profiles was collected in the form of gray value verses 
distance. Once plotted, the FWHM was determined for the peaks present at all 6 time 
points and averaged for each time point.   
 With all of the FWHM determined for each time point in 6 imaged cells, they 
were then averaged and plotted in Figure 4 (B).  A t-test was run to determine if there a 
significant difference in the cell-surface EGFR band at 5 minutes and at 30 minutes.  It 
was determined that their widths were not significally different (p=0.05), thus there was 
not a significant amount of EGFR internalized.  
   	
 
	 9	
	
 	
Figure 4: A) Example of line profile of an image acquired at 930nm at the 5-minute time point 
and the 30-minute time point.  Peaks display EGFR initial and final location within cell.  B) Plot 
of the average FWHM of 6 cells over 30 minutes.  The FWHM at 5 minutes and 30 minutes were 
not significantly different (p=0.05). 
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4. CONCLUSIONS 
 
 Triple negative breast cancer is an invasive breast cancer sub-type that currently 
lacks targeted agents.  Aiming to aid in the development of TNBC therapeutics, the 
internalization of EGFR was quantified using live-cell multiphoton microscopy on SK-
BR-3 cells over 30 minutes.  The cells were directly immunolabeled with Alexa Fluor 
488-conjugated mouse anti-EGFR mAb and DAPI and imaged at 930nm and 720nm, 
respectively.  The resulting time series images qualitatively showed the internalization of 
EGFR through the thickening of the EGFR band on the surface of the cell.  When the 
FWHM was taken for each time point within the series, however, it was quantitatively 
shown that no significant amount of EGFR was internalized between the 5-minute and 
30-minute time point.   
 
5. FUTURE DIRECTIONS 
 
 Moving forward, this experiment will be duplicated using a higher incident power 
during image acquisition.  It is believed this will enable better visualization of EGFR 
trafficking.  In addition, MDA-MB-468 cells, a TNBC cell line with EGFR 
overexpression, will be used to quantify EGFR internalization.  The MDA-MB-468 
results will be compared to the SK-BR-3 results to further determine the validity of 
EGFR as a TNBC therapeutic target.   
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